Bowman Consulting Group will ring the Nasdaq closing bell on December 19, 2025, to celebrate its acquisition of RPT Alliance and its entry into the bridging power engineering market.

Bowman Consulting Group has acquired RPT Alliance, a Houston-based engineering firm specializing in natural gas transmission and power generation infrastructure, for $59.7 million to expand its power and utilities services.

Bowman Consulting Group has acquired Lazen Power Engineering, a Florida-based power engineering firm specializing in high-voltage transmission line infrastructure design, to expand its energy services capabilities.

Bowman Consulting Group Ltd. has acquired Sierra Overhead Analytics and its technology affiliate ORCaS, Inc., expanding its energy practice and digital services portfolio with a focus on technology-enabled engineering services.

Bowman Consulting Group reported strong Q2 2025 financial results, exceeding analyst expectations with record revenue of $122.1 million, a 16.8% year-over-year increase. The company raised full-year guidance and demonstrated significant growth across multiple infrastructure service segments.

Bowman Consulting Group will release Q2 2025 financial results on August 6, and host a webcast on August 7. The company has been selected by USGS for aerial lidar collection and has entered a purchase agreement to acquire e3i Engineers.

Bowman Consulting Group secured a follow-up contract with the USDA's Natural Resources Inventory initiative to survey approximately 70,000 locations across 11.2 million acres in 2025, expanding their aerial imaging services and federal revenue stream.

In the preceding three months, 6 analysts have released ratings for Bowman Consulting Group (NASDAQ:BWMN), presenting a wide array of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 3 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $45.58, a high estimate of $49.00, and a low estimate of $36.50. Marking an increase of 2.2%, the current average surpasses the previous average price target of $44.60. Analyzing Analyst Ratings: A Detailed Breakdown The standing of Bowman Consulting Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Sherif El-Sabbahy B of A Securities Announces Buy $36.50 - Jeff Martin Roth MKM Lowers Buy $47.00 $49.00 Jeff Martin Roth MKM Maintains Buy $49.00 $49.00 Brent Thielman DA Davidson Raises Buy $45.00 $36.00 Jeff Martin Roth MKM Raises Buy $49.00 $45.00 Alex Rygiel B. Riley Securities Raises Buy $47.00 $44.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bowman Consulting Group. This information offers a snapshot of how analysts perceive the ...Full story available on Benzinga.com

Healthcare Services (HCSG) delivered earnings and revenue surprises of 22.22% and 0.04%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

4 analysts have expressed a variety of opinions on Bowman Consulting Group (NASDAQ:BWMN) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 3 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $47.5, a high estimate of $49.00, and a low estimate of $45.00. Surpassing the previous average price target of $43.50, the current average has increased by 9.2%. Decoding Analyst Ratings: A Detailed Look The standing of Bowman Consulting Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jeff Martin Roth MKM Maintains Buy $49.00 $49.00 Brent Thielman DA Davidson Raises Buy $45.00 $36.00 Jeff Martin Roth MKM Raises Buy $49.00 $45.00 Alex Rygiel B. Riley Securities Raises Buy $47.00 $44.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bowman Consulting Group. This information offers a snapshot of how analysts perceive the current state of the company. Rating: ...Full story available on Benzinga.com

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. LuxUrban said it expects preliminary revenue of $28.2 million for the fourth quarter, versus market estimates of $34.199 million, according to data from Benzinga Pro. LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers MariaDB plc (NYSE: MRDB) climbed 70.4% to $0.3850 after Progress Software announced that it is possibly considering an offer for the company. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 68.6% to $3.8099 after the company announced the publication of pre-clinical data on its lead clinical compound, LB-100. Nutriband Inc. (NASDAQ: NTRB) gained 33.2% to $3.9950 after the company provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Verb Technology Company, Inc. (NASDAQ: VERB) surged 30.5% to $0.3656 after the company announced that its MARKET.live entered into a formal partnership with TikTok to become a service provider for TikTok Shop and will receive a TikTok Shop Partner designation. PaySign, Inc. (NASDAQ: PAYS) gained 28.2% to $4.3299 after the company announced better-than-expected fourth-quarter results. Destiny Tech100 Inc (NASDAQ: DXYZ) rose 26.6% to $11.39 after gaining 9% on Tuesday. PAVmed Inc. (NASDAQ: PAVM) gained 19.7% to $2.4798 after the company issued business update and fourth quarter financial results. Noah Holdings Limited (NYSE: NOAH) rose 17.5% to $11.89 after the company reported fourth quarter financial results. NuScale Power Corporation (NYSE: SMR) rose 17.5% to $4.89. The ONE Group Hospitality, Inc. (NASDAQ: STKS) shares rose 17.2% to $4.70 after the company announced that it will ...

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Asana reported quarterly losses of 4 cents per share which beat the analyst consensus estimate of losses of 10 cents by 60%. Quarterly sales came in at $171.1 million, beating the analyst consensus estimate of $167.676 million by 2.04%. The company expects fiscal year 2025 adjusted losses of between 22 cents and 19 cents per share, versus the losses of 22 cents estimate and fiscal year revenues of between $716 million and $722 million, versus the $724.75 estimate. Asana shares dipped 11% to $16.72 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers ClearOne, Inc. (NASDAQ: CLRO) rose 168.4% to $2.4299. ClearOne announced a special one-time cash dividend of 50 cents per share. Regulus Therapeutics Inc. (NASDAQ: RGLS) climbed 74.3% to $2.4050 after the company announced topline results from the second cohort of patients in its Phase 1b MAD study of RGLS8429 for the treatment of ADPKD. The company announced an oversubscribed $100 million private placement of equity. Assure Holdings Corp. (NASDAQ: IONM) gained 49% to $0.4880. Assure Holdings entered into an agreement to sell certain of its assets to MPOWERHealth for up to $4.5 million. Ranpak Holdings Corp. (NASDAQ: PACK) shares gained 40.1% to $6.12 after the company reported better-than-expected fourth-quarter revenue results and issued FY24 guidance. Also, Baird maintained an Outperform rating on the stock and raised its price target from $5 to $7. Singularity Future Technology Ltd. (NASDAQ: SGLY) climbed 37.6% to $4.3321 after gaining over 6% on Monday. Li-Cycle Holdings Corp. (NASDAQ: LICY) gained 27.4% to $0.5111 after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore. Nukkleus Inc. (NASDAQ: NUKK) shares rose 22.5% to $1.41 after surging over 43% on Monday. ATRenew Inc. (NYSE: RERE) gained 17.7% to $1.4003 after the company ...